WHO ICTRP trial
The therapeutic effect of Melatonin, Metformin and Vitamin E in patients with…
IRCT2016040318124N3 · Iranian Registry of Clinical Trials (IRCT) · Not Recruiting
Key facts
| Trial ID | IRCT2016040318124N3 |
|---|---|
| Public title | The therapeutic effect of Melatonin, Metformin and Vitamin E in patients with non-alcoholic fatty liver disease |
| Scientific title | Compare the therapeutic effect of Melatonin, Metformin and Vitamin E on liver function, sugar and lipid factors in patients with non-alcoholic fatty liver disease (NAFLD) dietary regimen |
| Primary sponsor | Vice chancellor for research, Qazvin University of Medical Sciences |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Not Recruiting |
| Study type | interventional |
| Phase | 3 |
| Countries | Iran (Islamic Republic of) |
| Conditions | Nonalcoholic fatty liver disease [NAFLD]. Fatty (change of) liver, not elsewhere classified;Fatty (change of) liver, not elsewhere classified |
| Interventions | Intervention 1: Administration of melatonin (10 mg tablet) once a day with diet for a period of 3 months. Intervention 2: Administration of metformin (500 mg tablet) once a day with diet for a period of 3 months. Intervention 3… |
| Registration date | Apr 28, 2017 |
| Target size | 90 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: